Pharvaris Correlations
PHVS Stock | USD 15.88 0.12 0.75% |
The current 90-days correlation between Pharvaris BV and PepGen is 0.09 (i.e., Significant diversification). The correlation of Pharvaris is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
Pharvaris Correlation With Market
Modest diversification
The correlation between Pharvaris BV and NYA is 0.2 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Pharvaris BV and NYA in the same portfolio, assuming nothing else is changed.
Pharvaris |
Moving together with Pharvaris Stock
0.68 | NEO | NeoGenomics | PairCorr |
0.69 | BKRKF | PT Bank Rakyat | PairCorr |
0.71 | BKRKY | Bank Rakyat | PairCorr |
0.78 | PPERY | Bank Mandiri Persero | PairCorr |
0.71 | PPERF | Bank Mandiri Persero | PairCorr |
0.76 | PBCRY | Bank Central Asia | PairCorr |
0.76 | MCD | McDonalds Financial Report 25th of July 2024 | PairCorr |
0.65 | HD | Home Depot | PairCorr |
0.67 | CSCO | Cisco Systems Sell-off Trend | PairCorr |
Moving against Pharvaris Stock
0.74 | JPHLF | Japan Post Holdings | PairCorr |
0.67 | HPQ | HP Inc Fiscal Year End 19th of November 2024 | PairCorr |
0.66 | JPSTF | JAPAN POST BANK | PairCorr |
0.49 | MZHOF | Mizuho Financial | PairCorr |
0.42 | MRK | Merck Company Financial Report 6th of August 2024 | PairCorr |
0.64 | DD | Dupont De Nemours Financial Report 7th of August 2024 | PairCorr |
0.57 | T | ATT Inc Earnings Call Today | PairCorr |
0.53 | GE | GE Aerospace Financial Report 23rd of July 2024 | PairCorr |
0.5 | KO | Coca Cola Sell-off Trend | PairCorr |
0.41 | PFE | Pfizer Inc Sell-off Trend | PairCorr |
0.41 | PG | Procter Gamble Financial Report 26th of July 2024 | PairCorr |
0.35 | AXP | American Express Financial Report 19th of July 2024 | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Pharvaris Stock performing well and Pharvaris Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Pharvaris' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
PMVP | 2.97 | 0.10 | 0.02 | 0.08 | 3.99 | 6.42 | 23.74 | |||
ELYM | 6.92 | 2.25 | 0.45 | (1.04) | 3.99 | 20.98 | 86.31 | |||
MNOV | 2.30 | (0.03) | 0.00 | (0.03) | 0.00 | 6.98 | 14.01 | |||
PEPG | 4.29 | 0.51 | 0.09 | 3.73 | 5.51 | 11.00 | 27.70 | |||
MOLN | 3.61 | 0.38 | 0.07 | (0.20) | 4.25 | 8.11 | 28.42 | |||
MLYS | 2.34 | (0.08) | 0.00 | (0.05) | 0.00 | 5.02 | 17.32 | |||
ANTX | 2.71 | (0.53) | 0.00 | 0.57 | 0.00 | 4.95 | 25.27 | |||
GLUE | 4.05 | (0.42) | 0.00 | (0.16) | 0.00 | 7.66 | 31.83 | |||
DSGN | 3.87 | 0.67 | 0.18 | 0.26 | 3.20 | 11.97 | 37.04 | |||
HOWL | 3.66 | (0.92) | 0.00 | (1.05) | 0.00 | 5.75 | 39.88 |
Pharvaris Corporate Management
Peng MD | Chief Officer | Profile | |
Morgan Conn | Chief Officer | Profile | |
Jochen Knolle | Chief COO | Profile | |
CPA MBA | CEO CoFounder | Profile | |
Joan JD | Chief Officer | Profile | |
Stefan Abele | Chief Officer | Profile | |
Wim Souverijns | Chief Officer | Profile |